| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2013 | Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size | Lin Z.-Z.; Shau W.-Y.; Hsu C.; Shao Y.-Y.; Yeh Y.-C.; Kuo R.N.-C.; CHIH-HUNG HSU ; Yang J.C.-H.; Cheng A.-L.; Lai M.-S. | PLoS ONE | |||
| 2006 | Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent | Huang K.-M.; CHIH-HUNG HSU ; Cheng J.C.-H.; Lai M.-K.; Jeng S.-C.; Ting L.-L.; Huang W.-T. | Anticancer Research | |||
| 2020 | Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer | Kojima T.; Shah M.A.; Muro K.; Francois E.; Adenis A.; CHIH-HUNG HSU ; Doi T.; Moriwaki T.; Kim S.-B.; Lee S.-H.; Bennouna J.; Kato K.; Shen L.; Enzinger P.; Qin S.-K.; Ferreira P.; Chen J.; Girotto G.; de la Fouchardiere C.; Senellart H.; Al-Rajabi R.; Lordick F.; Wang R.; Suryawanshi S.; Bhagia P.; Peter Kang S.; Metges J.-P.; KEYNOTE-181 Investigators | Journal of Clinical Oncology | |||
| 2018 | Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma | Yang P.-C.; Guo J.-C.; Hsieh M.-S.; Lin C.-C.; CHIH-HUNG HSU | Journal of Thoracic Oncology | |||
| 2011 | Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma | Hsu F.-M.; Lee J.-M.; Huang P.-M.; Lin C.-C.; CHIH-HUNG HSU ; Tsai Y.-C.; Lee Y.-C.; Chia-Hsien Cheng J. | International Journal of Radiation Oncology Biology Physics | |||
| 2017 | Right or left? Side selection for a totally implantable vascular access device: A randomised observational study | Lin W.-Y.; Lin C.-P.; CHIH-HUNG HSU ; Lee Y.-H.; Lin Y.-T.; Hsu M.-C.; Shao Y.-Y. | British Journal of Cancer | |||
| 2017 | A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement | Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; CHIH-HUNG HSU ; Cheng A.-L.; Pu Y.-S. | Journal of the Formosan Medical Association | |||
| 2021 | Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab | Zhu A.X.; Finn R.S.; Kang Y.-K.; Yen C.-J.; Galle P.R.; Llovet J.M.; Assenat E.; Brandi G.; Motomura K.; Ohno I.; Daniele B.; Vogel A.; Yamashita T.; CHIH-HUNG HSU ; Gerken G.; Bilbruck J.; Hsu Y.; Liang K.; Widau R.C.; Wang C.; Abada P.; Kudo M. | British Journal of Cancer | |||
| 2012 | Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy | Shao Y.-Y.; Huang C.-C.; Lin S.-D.; CHIH-HUNG HSU ; Cheng A.-L. | Clinical Cancer Research | |||
| 2015 | Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy | Lu S.-L.; Hsu F.-M.; Tsai C.-L.; Wu J.-K.; Lee J.-M.; Huang P.-M.; CHIH-HUNG HSU ; Koong A.C.; Chang D.T.; Chia-Hsien Cheng J. | International Journal of Radiation Oncology Biology Physics | |||
| 2020 | Solving the deficit of cancer pain management skills by education programs | Shao Y.-Y.; Lin W.-Y.; Lin C.-P.; Lu L.-C.; CHIH-HUNG HSU | Supportive Care in Cancer | |||
| 2015 | Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan | Shao Y.-Y.; CHIH-HUNG HSU ; Yeh K.-H.; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S. | Clinical Colorectal Cancer | |||
| 2003 | Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma | Cheng A.-L.; Hsiung C.A.; Su I.-J.; Chen P.-J.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. | Hepatology | |||
| 2018 | Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure | Liu T.-H.; CHIH-HUNG HSU ; Shao Y.-Y. | Liver Cancer | |||
| 2005 | Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment | Yang C.-H.; Chen M.-C.; Cheng A.-L.; CHIH-HUNG HSU ; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C. | Oncology | |||
| 2004 | Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines | Kim T.E.; Park S.-Y.; CHIH-HUNG HSU ; Dutschman G.E.; Cheng Y.-C. | Molecular Pharmacology | |||
| 2015 | Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer | Huang T.-C.; CHIH-HUNG HSU ; Lin C.-C.; Tu Y.-K. | Japanese Journal of Clinical Oncology | |||
| 2008 | Systemic therapy for metastatic urothelial carcinoma | Lin C.-C.; CHIH-HUNG HSU ; Pu Y.-S.; Vogelzang N.J. | BJU International | |||
| 2011 | T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement | Kuo S.-H.; Cheng A.-L.; Lin C.-W.; CHIH-HUNG HSU ; Wu M.-S.; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T. | Cancer Chemotherapy and Pharmacology | |||
| 2018 | Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma | Chang C.-J.; Yang Y.-H.; Chiu C.-J.; Lu L.-C.; Liao C.-C.; Liang C.-W.; CHIH-HUNG HSU ; Cheng A.-L. | International Journal of Cancer |
